baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Cytokinetics Inc/ US23282W6057 /

2024-04-23 5:39:16 PM	Chg. +0.4900	Volume	Bid5:39:35 PM	Ask5:39:35 PM	High	Low
66.7800USD	+0.74%	292,318 Turnover: 14.39 mill.	66.7700Bid Size: 400	66.8900Ask Size: 300	68.7600	66.6500

GlobeNewswire 04-10 Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at t...

GlobeNewswire 04-05 Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Stu...

GlobeNewswire 04-02 Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 04-01 Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire 03-25 Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual...

GlobeNewswire 03-04 Cytokinetics to Participate in March Investor Conferences

GlobeNewswire 03-01 Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 02-29 Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day

GlobeNewswire 02-28 Cytokinetics, The Mended Hearts, Inc. and WomenHeart Announce Launch of New Initiative to Increase E...

GlobeNewswire 02-27 Cytokinetics Reports Fourth Quarter 2023 Financial Results

GlobeNewswire 02-15 Royalty Pharma Reports Q4 and Full Year 2023 Results

GlobeNewswire 02-13 Cytokinetics to Announce Fourth Quarter Results on February 27, 2024

GlobeNewswire 02-06 Cytokinetics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

GlobeNewswire 01-29 Cytokinetics Announces Recipients of Its Sixth Annual Communications Grant Program

GlobeNewswire 01-25 Cytokinetics Presents New Data at CMR 2024 From FOREST-HCM, the Open Label Extension Clinical Trial...

GlobeNewswire 01-18 Cytokinetics Announces New Data From FOREST-HCM to be Presented at CMR 2024

GlobeNewswire 01-03 Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 01-02 Cytokinetics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire 2023-12-27 Cytokinetics Announces Positive Results From SEQUOIA-HCM, the Pivotal Phase 3 Clinical Trial of Afi...

GlobeNewswire 2023-12-26 Cytokinetics to Host Investor Call on December 27 to Discuss the Topline Results from SEQUOIA-HCM, t...

GlobeNewswire 2023-12-12 Vanqua Bio Advances Clinical Candidate for Parkinson’s Disease, Expands Leadership Team to Support F...

GlobeNewswire 2023-12-07 Cytokinetics Presents Results From COURAGE-ALS at the 34th International Symposium on ALS/MND

GlobeNewswire 2023-12-01 Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 2023-11-29 Cytokinetics Announces Five Presentations at the 34th International Symposium on ALS/MND

Cytokinetics Inc/ US23282W6057 /

If you wish to receive reply to your feedback, please provide your email address.